Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Tables)

v3.24.3
Stock-Based Compensation (Tables)
9 Months Ended
Oct. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity
A summary of the Company’s stock option activity for the nine months ended October 31, 2024 is as follows:
Number of Stock Options
Weighted Average Exercise Price
Weighted Average Remaining Contractual Life
(in thousands) (in years)
Outstanding as of January 31, 2024
23,267  $ 6.66  5.9
Exercised (3,361) 5.59 
Forfeited
(864) 11.19 
Expired —  0.58 
Outstanding as of October 31, 2024
19,042  $ 6.65  5.0
Exercisable as of October 31, 2024
17,523  $ 6.20  4.8
Vested and expected to vest as of October 31, 2024
18,974  $ 6.64  5.0
Schedule of RSU Award Activity
A summary of the Company’s RSU activity for the nine months ended October 31, 2024 is as follows:
Number of Restricted Stock Units
Weighted Average Grant Date Fair Value
(in thousands)
Outstanding as of January 31, 2024
9,259  $ 12.61 
Granted 10,682  10.53 
Released (2,678) 12.74 
Forfeited
(2,728) 12.20 
Outstanding as of October 31, 2024
14,535  $ 11.13 
Schedule of Stock-based Compensation Expense
Stock-based compensation expense included in operating results was allocated as follows:
Three Months Ended October 31, Nine Months Ended October 31,
(in thousands) 2024 2023 2024 2023
Costs of subscription $ 335  $ 268  $ 945  $ 858 
Costs of professional services 400  331  1,081  1,139 
Research and development 2,896  2,128  8,304  9,092 
Sales and marketing 5,091  6,132  16,497  18,398 
General and administrative 6,508  5,071  17,350  12,618 
Stock-based compensation, net of amounts capitalized 15,230  13,930  44,177  42,105 
Capitalized stock-based compensation 643  412  1,825  1,956 
Total stock-based compensation $ 15,873  $ 14,342  $ 46,002  $ 44,061